Aronsson B - Search Results

1

New drug approval success rate in Europe in 2009.

Eichler HG, Aronsson B, Abadie E, Salmonson T. Eichler HG, et al. Among authors: aronsson b. Nat Rev Drug Discov. 2010 May;9(5):355-6. doi: 10.1038/nrd3169. Nat Rev Drug Discov. 2010. PMID: 20431561 No abstract available.

2

Factors associated with success of market authorisation applications for pharmaceutical drugs submitted to the European Medicines Agency.

Regnstrom J, Koenig F, Aronsson B, Reimer T, Svendsen K, Tsigkos S, Flamion B, Eichler HG, Vamvakas S. Regnstrom J, et al. Among authors: aronsson b. Eur J Clin Pharmacol. 2010 Jan;66(1):39-48. doi: 10.1007/s00228-009-0756-y. Epub 2009 Nov 20. Eur J Clin Pharmacol. 2010. PMID: 19936724

3

Factors influencing non-approval of new drugs in Europe.

Putzeist M, Mantel-Teeuwisse AK, Aronsson B, Rowland M, Gispen-de Wied CC, Vamvakas S, Hoes AW, Leufkens HG, Eichler HG. Putzeist M, et al. Among authors: aronsson b. Nat Rev Drug Discov. 2012 Dec;11(12):903-4. doi: 10.1038/nrd3894. Nat Rev Drug Discov. 2012. PMID: 23197028 No abstract available.

4

Clinical trials for registration in the European Union: the EMEA 5-year experience in oncology.

Pignatti F, Aronsson B, Vamvakas S, Wade G, Papadouli I, Papaluca M, Moulon I, Le Courtois P. Pignatti F, et al. Among authors: aronsson b. Crit Rev Oncol Hematol. 2002 May;42(2):123-35. doi: 10.1016/s1040-8428(02)00009-4. Crit Rev Oncol Hematol. 2002. PMID: 12007970 Review.

5

The review of drug applications submitted to the European Medicines Evaluation Agency: frequently raised objections, and outcome.

Pignatti F, Aronsson B, Gate N, Vamvakas S, Wade G, Moulon I, Le Courtois P. Pignatti F, et al. Among authors: aronsson b. Eur J Clin Pharmacol. 2002 Dec;58(9):573-80. doi: 10.1007/s00228-002-0532-8. Epub 2002 Nov 13. Eur J Clin Pharmacol. 2002. PMID: 12525957

6

Critical shortage of new antibiotics in development against multidrug-resistant bacteria-Time to react is now.

Freire-Moran L, Aronsson B, Manz C, Gyssens IC, So AD, Monnet DL, Cars O; ECDC-EMA Working Group. Freire-Moran L, et al. Among authors: aronsson b. Drug Resist Updat. 2011 Apr;14(2):118-24. doi: 10.1016/j.drup.2011.02.003. Epub 2011 Mar 23. Drug Resist Updat. 2011. PMID: 21435939 Review.

7

[New recommendations for antibiotics in dental care also relevant for physicians].

Edlund C, Aronsson B. Edlund C, et al. Among authors: aronsson b. Lakartidningen. 2014 Feb 26-Mar 11;111(9-10):406. Lakartidningen. 2014. PMID: 24707559 Swedish. No abstract available.

8

[New treatment recommendations: Management of pharyngo-tonsillitis in ambulatory care].

Aronsson B, Claesson K. Aronsson B, et al. Lakartidningen. 2012 Dec 19-2013 Jan 8;109(51-52):2367. Lakartidningen. 2012. PMID: 23367554 Swedish. No abstract available.

9

[Increased prescription of azithromycin: New recommendations on the way for sexually transmitted infections caused by bacteria].

Aronsson B, Wisell KT. Aronsson B, et al. Lakartidningen. 2013 Dec 4-17;110(49-50):2253. Lakartidningen. 2013. PMID: 24494403 Swedish. No abstract available.

10

[Routine ultrasonography during pregnancy. Fetal diseases are discovered without screening for abnormalities].

Nordström L, Aronsson B, Hallqvist T, Hultman M, Karlsson A, Spetz E, Sundqvist E. Nordström L, et al. Among authors: aronsson b. Lakartidningen. 1995 Mar 29;92(13):1348-50. Lakartidningen. 1995. PMID: 7707780 Swedish. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters